Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 0941820140240030199
Korean Journal of Clinical Pharmacy
2014 Volume.24 No. 3 p.199 ~ p.205
Effect of Phosphate Binders on Vascular Calcification and Mortality in Korean Patients with Chronic Kidney Disease
Sin Hye-Yeon

Abstract
Objectives: Current studies are debating on the association of vascular calcification and the benefit of treatment to
lower serum phosphorus level in patients with chronic kidney disease. The aim of this study was to evaluate the association of mortality and risk of vascular calcification in patients with CKD who were taking phosphate binders.
Methods: This study was conducted through retrospective medical chart review for 420 patients aged 18 years and older who were admitted for chronic kidney disease.

Results: Vascular calcification was not statistically significantly associated with increased mortality in patients with CKD [16.7% vs. 19.2%; 95% CI; 0.388 to 1.818 (p=0.656)]. Intervention of calcium-based phosphate binders was not significantly associated with vascular calcification in patients with CKD [9.1% vs. 12.5%; 95% CI; 0.364 to 1.358 (p=0.292)]. Ca x P product ¡Ã 55 mg2/dL2 was not significantly associated with increased 1 year mortality in patients with CKD [25.4% vs. 17.5%; 95% CI; 0.851 to 3.013 (p=0.142)]. Intervention of sevelamer was significantly associated with reduced 1 year mortality in patients with CKD than that of patients who did not take sevelamer [6.3% vs. 25.3%; 95% CI; 0.044 to 0.880 (p=0.020)].

Conclusion: There was not a statistically significant association between vascular calcification and phosphate binder¡¯s use. But phosphate binder use was significantly associated with decreased mortality in patients with CKD.
KEYWORD
chronic kidney disease, vascular calcification, mortality, phosphate binders
FullTexts / Linksout information
Listed journal information
ÇмúÁøÈïÀç´Ü(KCI)